Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis
- 1 July 2020
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 528 (10), 1704-1724
- https://doi.org/10.1002/cne.24845
Abstract
Neurodegeneration, including loss of neurons and axons, is a feature of progressive forms of multiple sclerosis (MS). The mechanisms underlying neurodegeneration are mostly unknown. Research implicates autoimmunity to nonmyelin self-antigens as important contributors to disease pathogenesis. Data from our lab implicate autoimmunity to the RNA binding protein (RBP) heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) as a possible mechanism of neurodegeneration in MS. MS patients make antibodies to hnRNP A1, which have been shown to lead to neuronal dysfunction in vitro. Using an animal model of MS, experimental autoimmune encephalomyelitis (EAE), we show here that injection of anti-hnRNP A1 antibodies, in contrast to control antibodies, resulted in worsened disease and increased neurodegeneration. We found a reduction of NeuN(+) neuronal cell bodies in areas of the ventral gray matter of the spinal cord where anti-hnRNP A1 antibodies localized. Neurons displayed increased levels of hnRNP A1 nucleocytoplasmic mislocalization and stress granule formation, both markers of neuronal injury. Anti-hnRNP A1 antibodies were found to surround neuronal cell bodies and interact with CD68(+) immune cells via Fc receptors. Additionally, anti-hnRNP A1 antibodies were found within neuronal cell bodies including those of the ventral spinocerebellar tract (VSCT), a tract previously shown to undergo neurodegeneration in anti-hnRNP A1 antibody injected EAE mice. Finally, both immune cells and neurons showed increased levels of inducible nitric oxide synthase, another indicator of cell damage. These findings suggest that autoimmunity to RBPs, such as hnRNP A1, play a role in neurodegeneration in EAE with important implications for the pathogenesis of MS.Keywords
Funding Information
- Saskatchewan Health Research Foundation (4244)
This publication has 65 references indexed in Scilit:
- Antibodies to an Intracellular Antigen Penetrate Neuronal Cells and Cause Deleterious EffectsAlternative & Integrative Medicine, 2013
- Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic diseaseDegenerative Neurological and Neuromuscular Disease, 2012
- Excitatory inputs to four types of spinocerebellar tract neurons in the cat and the rat thoraco‐lumbar spinal cordThe Journal of Physiology, 2012
- A potential link between autoimmunity and neurodegeneration in immune-mediated neurological diseaseJournal of Neuroimmunology, 2011
- Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43Nature Neuroscience, 2011
- Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain TissuePLOS ONE, 2010
- Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 responseNeuroscience Letters, 2004
- Increased Production of Tumor Necrosis Factor-αInduces Apoptosis after Traumatic Spinal Cord Injury in RatsJournal of Neurotrauma, 2003
- NITRIC OXIDE: ROLE IN NEUROTOXICITYClinical and Experimental Pharmacology and Physiology, 1995
- Origin of spinal projections to the anterior and posterior lobes of the rat cerebellumJournal of Comparative Neurology, 1991